Cargando…

Personalised mapping of tumour development in synchronous colorectal cancer patients

Synchronous colorectal cancers (syCRCs) are two or more primary tumours identified simultaneously in a patient. Previous studies report high inter-tumour heterogeneity between syCRCs, suggesting independent origin and different treatment response, making their management particularly challenging, wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Valentina, Cotter, Maura B., Tosetto, Miriam, Khaw, Yi Ling, Geraghty, Robert, Winter, Desmond C., Ryan, Elizabeth J., Sheahan, Kieran, Furney, Simon J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335056/ https://www.ncbi.nlm.nih.gov/pubmed/32655884 http://dx.doi.org/10.1038/s41525-020-0134-3

Ejemplares similares

Estrogen Receptors and Their Implications in Colorectal Carcinogenesis
por: Caiazza, Francesco, et al.
Publicado: (2015)

Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer
por: Michielsen, Adriana J., et al.
Publicado: (2011)

Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4(+) T Cells within Colorectal Tumors despite the Presence of Elevated CD39(+) T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1
por: Dunne, Margaret R., et al.
Publicado: (2016)

Characterising the prognostic potential of HLA-DR during colorectal cancer development
por: Dunne, Margaret R., et al.
Publicado: (2020)

Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive
por: O'Toole, A, et al.
Publicado: (2014)

Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment
por: Noonan, Sinead A., et al.
Publicado: (2018)

A personalised medicine approach for ponatinib-resistant chronic myeloid leukaemia
por: Korfi, K., et al.
Publicado: (2015)

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer
por: Martin, Petra, et al.
Publicado: (2014)

Personalised neoantigen‐based therapy in colorectal cancer
por: Zhu, Ya‐Juan, et al.
Publicado: (2023)

Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
por: Rogers, A C, et al.
Publicado: (2016)

Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair‐deficient colorectal cancer
por: Ryan, É. J., et al.
Publicado: (2018)

Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
por: Smith, G, et al.
Publicado: (2010)

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer
por: Murphy, Adrian G., et al.
Publicado: (2016)

Nuclear oxidative damage correlates with poor survival in colorectal cancer
por: Sheridan, J, et al.
Publicado: (2009)

Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme
por: McCarthy, A. J., et al.
Publicado: (2019)

Development of a Personalised Device for Systemic Magnetic Drug Targeting to Brain Tumours
por: Patel, Priya, et al.
Publicado: (2023)

Oncotherapeutic Strategies in Early Onset Colorectal Cancer
por: O’Reilly, Mary, et al.
Publicado: (2023)

Imaging Biomarkers of Tumour Proliferation and Invasion for Personalised Lung Cancer Therapy
por: Marcu, Loredana G.
Publicado: (2020)

Multiple primary malignancies: synchronous lymphoma, pancreatic neuroendocrine tumour and colorectal cancer
por: Dayer, Nicolas, et al.
Publicado: (2021)

Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer
por: Ryoo, Seung-Bum, et al.
Publicado: (2023)

Personalised Ecology
por: Gaston, Kevin J., et al.
Publicado: (2018)

An Analysis of Clinicopathological Outcomes and the Utility of Preoperative MRI for Patients Undergoing Resection of Mucinous and Non-Mucinous Colorectal Cancer Liver Metastases
por: Reynolds, Ian S., et al.
Publicado: (2022)

Personalised colorectal cancer screening strategies: Information needs of the target population
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer
por: Ascolani, Gianluca, et al.
Publicado: (2015)

Synchronous tumours of the breast and bladder
por: Wallace, David, et al.
Publicado: (2014)

Lynch Syndrome: An Updated Review
por: Sehgal, Rishabh, et al.
Publicado: (2014)

Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial
por: de Hosson, L. D., et al.
Publicado: (2019)

Synchronous polypectomy during endoscopic diagnosis of colorectal cancer – is the risk of tumour implantation at the polypectomy site significant?
por: Tan, W. J., et al.
Publicado: (2018)

Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers
por: O'Kane, Grainne M., et al.
Publicado: (2017)

A patient tumour-on-a-chip system for personalised investigation of radiotherapy based treatment regimens
por: Kennedy, R., et al.
Publicado: (2019)

Personalised diet
Publicado: (2011)

Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives
por: Pellino, Gianluca, et al.
Publicado: (2018)

Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing
por: Mogensen, M. B., et al.
Publicado: (2018)

Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm
por: Ryan, Éanna J., et al.
Publicado: (2020)

Insights into Personalised Medicine in Bronchiectasis
por: Fraser, Clementine S., et al.
Publicado: (2023)

JOCR: Personalised Journal, Personalised Network and Clinical Decision Making (CDM)
por: Shyam, Ashok
Publicado: (2012)

Clinical Proteomics in Colorectal Cancer, a Promising Tool for Improving Personalised Medicine
por: Chauvin, Anaïs, et al.
Publicado: (2018)

Personalised Medicine for Colorectal Cancer Using Mechanism-Based Machine Learning Models
por: Nwaokorie, Annabelle, et al.
Publicado: (2021)

Isolation and gene expression profiling of intestinal epithelial cells: crypt isolation by calcium chelation from in vivo samples
por: Balfe, Aine, et al.
Publicado: (2018)

Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity
por: Fisher, Rosalie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5o24ekmntea0nvd80ncb163man